AAIC 2019: Are we one step closer to finding a blood test for Alzheimer’s?

Abstracts presented at the Alzheimer’s Association International Conference (14–18 July 2019, Los Angeles, CA, USA) have illustrated various advances in in the field of blood biomarkers for Alzheimer’s disease and other dementias. This includes approaches for measuring abnormal versions of amyloid in the blood and correlating it wish established Alzheimer’s markers, and new methods for assessing α-synuclein in blood. “These new testing technologies, which are currently under development by industry and academic researchers, could also potentially be used to track the impact of therapies in clinical trials,” explained Maria Carrillo, Chief Science Officer at the Alzheimer’s Association (IL, USA). Is...